Recall Rate

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

H
HologicMA - Marlborough
1 program
Digital breast tomosynthesisN/A1 trial
Active Trials
NCT01248546Unknown25,000Est. Sep 2015

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
HologicDigital breast tomosynthesis

Clinical Trials (1)

Total enrollment: 25,000 patients across 1 trials

NCT01248546HologicDigital breast tomosynthesis

Tomosynthesis in the Oslo Breast Cancer Screening Program

Start: Nov 2010Est. completion: Sep 201525,000 patients
N/AUnknown

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space